Johnson & Johnson

JNJ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2019 FY2018 FY2017
Assets
Cash & Equivalents $19.71B $24.11B $21.86B $14.49B $13.99B $17.31B $18.11B $17.82B
Accounts Receivable $17.18B $14.84B $14.87B $15.28B $13.58B $14.48B $14.10B $13.49B
Inventory $14.19B $12.44B $11.18B $10.39B $9.34B $9.02B $8.60B $8.77B
Total Current Assets $55.62B $55.89B $53.50B $60.98B $51.24B $45.27B $46.03B $43.09B
Property, Plant & Equipment $23.17B $20.52B $19.90B $18.96B $18.77B $17.66B $17.04B $17.01B
Goodwill $48.77B $44.20B $36.56B $25.44B $36.39B $33.64B $30.45B $31.91B
Intangible Assets (Excl. Goodwill) $50.40B $37.62B $34.18B $46.39B $53.40B $47.64B $47.61B $53.23B
Total Assets $199.21B $180.10B $167.56B $182.02B $174.89B $157.73B $152.95B $157.30B
Liabilities
Accounts Payable $11.99B $10.31B $9.63B $11.06B $9.51B $8.54B $7.54B $7.31B
Total Current Liabilities $54.13B $50.32B $46.28B $45.23B $42.49B $35.96B $31.23B $30.54B
Long-Term Debt $39.44B $30.65B $25.88B $29.99B $32.64B $26.49B $27.68B $30.68B
Total Liabilities $117.67B $108.61B $98.78B $108.00B $111.62B $98.26B $93.20B $97.14B
Stockholders' Equity
Retained Earnings $168.98B $155.79B $153.84B $123.06B $113.89B $110.66B $106.22B $101.79B
Total Stockholders' Equity $81.54B $71.49B $68.77B $74.02B $63.28B $59.47B $59.75B $60.16B
← Newer Page 1 of 2 Older →